Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

4 Stocks To Watch Today: ACAD, AMRN, ASMC, PRQR

Published 11/04/2018, 02:22 AM
Updated 07/09/2023, 06:31 AM

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) popped 2.88, or 15%, to 22.36, on 3.6 million shares on Thursday. Looking at the overall structure, this stock exploded, pulled back, and I gave you a swing on it. Then it went from 19 to 23, and change, but it pulled back when the market did. You can see that right now it looks like this remains the platform and you’ve got to keep a stop under 19. I’m looking for this stock to make it out over 23 1/2 and run to the 26-28 zone. The secondary target is 33, or thereabout.

Amarin Corporation PLC (NASDAQ:AMRN) has a great chart, and what a great company. Just a fantastic chart, folks. When you have a big gap and it won’t back down, it just keeps going up in a rising flag or pattern. Look at Thursday. At 22.64, this stock never closed this high before, jumping 1.81, or 9%, on 13 million shares. I think it’s going higher. The next target is 22 1/2.

American Superconductor Corporation (NASDAQ:AMSC), which I gave you a swing on Thursday, popped 1.56, or 26%, to 7.55, on 675,200 shares traded. I just like the overall structure of this stock. The base, the breakout, it crawled up the 60-day moving average, and then got slammed back to support. In this zone, it bounced back up, and on Thursday, may have broken out. Thursday was a big key, and the volume was the best since January when it exploded. I’m looking for this stock to get to 9 1/2, but on a longer-term basis, this stock could be headed to 12 1/2, if not more.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ProQR Therapeutics NV (NASDAQ:PRQR) shot up 3.97, or 22%, to 22.17, on 542,700 shares traded on Thursday. It has got to take out the double-top at 22.85, however, it did get closer to that number at 22.67. If it can get though here, I will be looking or 27 3/4 for the next target.

Stocks on the long side included ACADIA Pharmaceuticals Inc. (ACAD), Amarin Corporation plc (AMRN), Array BioPharma Inc. (ARRY), Attunity Ltd. (ATTU), AudioCodes Ltd. (AUDC), Clovis Oncology, Inc. (CLVS), FormFactor, Inc. (FORM), Globus Maritime Limited (GLBS), Direxion Daily S&P Biotech Bull 3X ETF (LABU), Luxfer Holdings PLC (LXFR), MiX Telematics Limited (MIXT), NXP Semiconductors N.V. (NXPI), Pacira Pharmaceuticals, Inc. (PCRX), PGT Innovations, Inc. (PGTI), ProQR Therapeutics N.V. (PRQR), Proteostasis Therapeutics, Inc. (PTI), QuinStreet, Inc. (QNST), Repligen Corporation (RGEN), Stratasys Ltd. (SSYS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Tandem Diabetes Care, Inc. (TNDM), U.S. Concrete, Inc. (USCR), Viking Therapeutics, Inc. (VKTX), and Xilinx, Inc. (NASDAQ:XLNX).

Watch video here.

Latest comments

Great , I love $ACAD from 14ish
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.